Term ends May 16, 2033 · High confidence
20-year base term ends Mar 16, 2030
Held by Pangu Biopharma Limited
Filed Jun 23, 2021 as application 17/355,587 · Granted Dec 16, 2025
Base term plus 1157 days of patent term adjustment (USPTO delay)
Today
2010
2033
Clock starts
Mar 16, 2010
Mar 16, 2010
Term ends
May 16, 2033
May 16, 2033
Granted
Dec 16, 2025
Dec 16, 2025
base term
patent term adjustment
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,157
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
9
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 1157 days past its 20-year base term on prosecution delay. 0 of 1 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 16, 2010, when application 12/725,272, the earliest non-provisional in its chain, was filed (this one was filed Jun 23, 2021) | Mar 16, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1157 days, USPTO patent term adjustment record | May 16, 2033 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 16, 2033 | High confidence |
This family
| US 8,404,242 | In force Feb 2031 | Feb 2031 |
| US 8,753,638 | In force Mar 2030 | Mar 2030 |
| US 9,605,265 | In force Mar 2030 | Mar 2030 |
| US 10,017,582 | In force Mar 2030 | Mar 2030 |
| US 10,526,419 | In force Mar 2030 | Mar 2030 |
| US 10,941,214 | In force Mar 2030 | Mar 2030 |
| US 11,078,299 | In force Mar 2030 | Mar 2030 |
| US 12,497,466 | this patent May 2033 | May 2033 |
8 of 9 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 19, 2022 Reel 61472, frame 369 | Zhou, Jie; Lau, Ching Fun; Xu, Zhiwen; Lo, Wing Sze; Piehl, Kristi Helen; Greene, Leslie Ann | Atyr Pharma, Inc. | Assignment of Assignor's Interest |
| Oct 19, 2022 Reel 61472, frame 472 | Zhou, Jie; Lau, Ching Fun; Xu, Zhiwen; Lo, Wing-sze | Pangu Biopharma Limited | Assignment of Assignor's Interest |
| Oct 19, 2022 Reel 61472, frame 531 | Pangu Biopharma Limited | Atyr Pharma, Inc. | Assignment of Assignor's Interest |
| Oct 19, 2022 Reel 61726, frame 816 | Atyr Pharma, Inc. | Pangu Biopharma Limited | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
May 2033
Term ends May 16, 2033. Maintenance fees still fall due before then
Note
The 1157 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
2
later US patents cite this one
Fewer than half of the utility patents granted in 2025 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.